Goldstein, L., et al. A randomized, placebo-controlled phase 2 study paclitaxel in combination with reparixin compared to paclitaxel alone as front-l ine therapy for metastatic Triple -Negative Breast Cancer (fRida) . in San Antonio Br east Cancer Symposium .